España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Zacks Small Cap Research
MIRA Announces Positive Test Results
By Brad Sorensen, CFA READ THE FULL MIRA RESEARCH REPORT
ADAP: Initiating Coverage of Adaptimmune, a Leading T-Cell Therapy Company
By Michael Kim READ THE FULL ADAP RESEARCH REPORT
NVX: Positive Takeaways Recent EV Sales Trends
By M. Marin EV + hybrids 12.7% of Ford's ‘24 vehicle sales to-date vs 8.3% in same period of ‘23…
BBLG Continues Progress as Testing Proceeds
By Brad Sorensen, CFA READ THE FULL BBLG RESEARCH REPORT
Initiating Coverage of a Southeast Asian Community-Based Buying Group
By Brian Lantier, CFA We are initiating coverage of Webuy Global (NASDAQ: WBUY) with a $0.85 target valuation.
TRC: Annual Meeting Next Month; Stockholder Issues Letter to Others
Shareholder letter regarding next month's annual meeting
Advancements in Medical Device Innovation
ADM Tronics (OTC: ADMT) is a diversified technology company, specializing in the development and manufacturing of innovative products across three primary areas including Proprietary Electronic Medical Devices, Engineering, Regulatory, and Manufacturing Services, and Eco-Friendly, Water-Based Formulations.
LuxUrban Hotels Improvements in Working Capital and Free Cash Flow in 2024 Supports Price Target of $5.00
By Thomas Kerr, CFA
SNGX: Agreement with EMA on Second Confirmatory Trial for HyBryte™
By David Bautz, PhD Business Update Reaches Agreement with European Medicines Agency on Second Confirmatory Trial for HyBryte™
CRVO: $150 Million Financing Strengthens Balance Sheet; Topline Data for Phase 2b Trial in 4Q24
By David Bautz, PhD Business Update Biomarker Data Presented at AD/PD 2024
Sadot Group Potential Profitable Growth Going Forward Supports Price Target of $3.50.
By Thomas Kerr, CFA
IR-Med's Potential for Profitable Growth in Coming Years Supports Price Target of $3.00
By Thomas Kerr, CFA
HTCR: HeartCore Announces Sale of $9.0 Million in Go IPO Client Warrants
By Thomas Kerr, CFA
BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research
The below report was authored by Brad Sorensen, CFA, Zacks Small Cap Research. You can find the original report here.
Sponsored
PNDHF: Insider Participation in Private Placement Underscores Management's Confidence in Company Prospects
By M. Marin OTCQB:PNDHF | TSX.V:POND READ THE FULL PNDHF RESEARCH REPORT
FRXIF: A Stock On the Cusp of Catching On Fire
By Brad Sorensen, CFA OTC:FRXIF READ THE FULL FRXIF RESEARCH REPORT
FRXIF: A Stock On the Cusp of Catching On Fire
By Brad Sorensen, CFA OTC:FRXIF READ THE FULL FRXIF RESEARCH REPORT
CLMEF: An Energy Company with an Enticing Yield
By Brad Sorensen, CFA OTC:CLMEF
VSQTF: Q2 Report at Victory Square Shows Rapid Growth at IV Hydreight and XR Immersive
By Lisa Thompson OTC:VSQTF READ THE FULL VSQTF RESEARCH REPORT
GBLI: INITIATION: Smallcap specialty property & casualty insurer entering a new and focused growth phase. The company operates in specialty areas primarily in excess and surplus lines.
By Thomas Kerr, CFA NYSE:GBLI READ THE FULL GBLI RESEARCH REPORT